George D. Demetri's most recent trade in Blueprint Medicines Corp was a trade of 5,300 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 21, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 5,300 | 5,300 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 2,600 | 8,412 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | George D. Demetri | Director | Sale of securities on an exchange or to another person at price $ 58.60 per share. | 21 Jun 2022 | 10 | 5,812 (0%) | 0% | 58.6 | 586 | Common Stock |
| Blueprint Medicines Corp | George D. Demetri | Director | Purchase of securities on an exchange or from another person at price $ 82.70 per share. | 21 Jun 2022 | 10 | 5,822 (0%) | 0% | 82.7 | 827 | Common Stock |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,500 | 4,500 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | George D. Demetri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 2,250 | 5,812 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | George D. Demetri | Director | Sale of securities on an exchange or to another person at price $ 112.15 per share. | 04 Jan 2021 | 758 | 3,562 (0%) | 0% | 112.2 | 85,010 | Common Stock |